Gilead Sciences | Vermögenswerte



Assets Veränderung Datum
AbbVie USD 136.17B 1B 2025-03
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
ALKERMES USD 2.25B 170.83M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 87.9B 1.47B 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.82B 71.99M 2025-06
J&J USD 193.67B 13.57B 2025-03
Merck USD 117.52B 2.4B 2025-06
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 206.1B 1.93B 2025-06
PTC Therapeutics USD 2.63B 21.23M 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Sanofi 124.96B 6.93B 2025-06
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
United Therapeutics USD 7.91B 164.1M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


Gilead Sciences Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.